Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 287
interventional 245
Observational 38
Registry 4

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 91
Drug|Radiation 40
Biological 20
Drug|Other 16
Radiation 16
Biological|Drug|Other 7
Biological|Drug 5
Drug|placebo 5
Device 4
Other 4
Procedure 4
Drug|Other|Radiation 3
Drug|Procedure 3
Biological|Drug|Radiation 2
Biological|Other 2
Combination Product|Drug 2
Dietary Supplement 2
Drug|Other|placebo 2
Drug|Other|Procedure|Radiation 2
Behavioral|Device 1
Behavioral|Other 1
Biological|Drug|Other|placebo|Procedure 1
Biological|Drug|Other|Radiation 1
Biological|Procedure 1
Device|Drug|Radiation 1
Device|placebo 1
Diagnostic Test 1
Dietary Supplement|Procedure 1
Drug|Genetic|Other|Radiation 1
Drug|Other|Procedure 1
Drug|placebo|Procedure 1
Drug|Procedure|Radiation 1
Other|Procedure 1
Procedure|Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
China 124
United States 62
Hong Kong 9
NA 9
Singapore 7
Taiwan 5
Canada 3
United States|Canada 2
United States|China|Singapore 2
Algeria|Brazil|China|France|India|Indonesia|Italy|Korea, Republic of|Mexico|Morocco|Philippines|Thailand|Tunisia|Turkey 1
Belgium 1
Brazil 1
China|Singapore 1
China|Taiwan|Thailand 1
Hong Kong|Indonesia|Malaysia|Taiwan|Thailand 1
Hong Kong|Singapore 1
Italy 1
Kuwait 1
Malaysia 1
Morocco 1
Saudi Arabia 1
United Kingdom 1
United States|Australia|Canada 1
United States|Australia|Canada|China|Hong Kong|Puerto Rico|Singapore|Taiwan 1
United States|Belgium 1
United States|Canada|France|Greece|Italy|Singapore|Spain|Taiwan|Tunisia 1
United States|China|France|Hong Kong|Singapore 1
United States|China|France|Hong Kong|Singapore|Taiwan|Thailand 1
United States|Germany|Hong Kong|Japan 1
United States|Malaysia|Singapore|Taiwan|Thailand 1
United States|Singapore 1

Sites per Study

Site_count Study_Count
1 173
2 18
3 6
4 6
5 5
6 7
7 1
8 4
9 4
10 1
11 2
12 2
13 1
15 1
17 2
18 1
19 1
21 1
23 1
25 1
26 1
30 1
42 1
91 1
108 1
191 1
938 1

Phase

Phase Study_Count
Phase 2 101
Phase 3 51
Phase 1 40
Phase 1/Phase 2 25
N/A 20
Phase 2/Phase 3 5
Phase 4 2
Early Phase 1 1

Number of Arms

Number_of_Arms Count_of_Studies
1 112
2 113
3 5
4 7
5 1
6 1
NA 6

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 9 10.00 3.00000 18.00 9.00000 120.0 50.000 19.00
1st Qu. 9 53.75 18.00000 25.00 37.00000 120.0 202.000 42.75
Median 9 146.00 27.00000 48.00 60.00000 180.0 300.000 66.50
Mean 9 145.70 50.51282 64.44 88.65347 291.2 305.902 66.50
3rd Qu. 9 182.25 42.50000 60.00 118.00000 278.0 413.000 90.25
Max. 9 386.00 320.00000 403.00 818.00000 758.0 803.000 114.00

Trial Group Type

group_type Group_Count
Experimental 274
Active Comparator 81
Placebo Comparator 14
No Intervention 13
Other 9
NA 6
Sham Comparator 1

Intervention Model

intervention_model Study_Count
Parallel Assignment 119
Single Group Assignment 118
Sequential Assignment 3
NA 3
Factorial Assignment 2

Primary Purpose

primary_purpose Study_Count
Treatment 226
Supportive Care 6
Prevention 5
Diagnostic 3
Other 2
Basic Science 1
Health Services Research 1
NA 1

Observational Studies

Studies by Country

Country Study_Count
China 16
NA 5
Hong Kong 4
United States 4
Canada 2
Taiwan 2
Australia 1
Italy 1
Singapore 1
Spain 1
United Kingdom 1

Sites per Study

Site_count Study_Count
1 36
6 1
15 1

Enrollment Metrics

Measure Observational
Min 17.000
1st Qu 95.500
Median 176.000
Mean 1991.737
3rd Qu 716.500
Max 25000.000

Observation Model

observational_model Study_Count
Cohort 22
Case-Only 10
Case Control 2
Case-Control 1
Family-Based 1
Other 1
NA 1

Time Perspective

time_perspective Study_Count
Prospective 27
Retrospective 9
Cross-Sectional 2

Registries

Studies by Country

Country Study_Count
China 2
NA 1
United States 1

Sites per Study

Site_count Study_Count
1 3
75 1

Enrollment Metrics

Measure Registries
Min 149.00
1st Qu 4123.25
Median 7724.00
Mean 253899.00
3rd Qu 257499.75
Max 999999.00

Registry Model

observational_model Study_Count
Cohort 4

Time Perspective

time_perspective Study_Count
Prospective 4

Follow-up

target_duration Study_Count
5 Years 2
10 Years 1
80 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03175939 Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03175939 Completed Sun Yat-sen University 2008-12-31
NCT04453813 Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT04453813 Recruiting Sun Yat-sen University 2025-07-31
NCT03682055 Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC) https://ClinicalTrials.gov/show/NCT03682055 Active, not recruiting Cullinan Oncology, LLC 2021-10-31
NCT03389295 Reduced Target Delineation and Radiation Doses Chemoradiotherapy for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03389295 Completed Fudan University 2019-04-30
NCT03346109 To Study the Feasibility and Quality of Life of Medial Group Retropharyngeal Node Sparing in Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03346109 Recruiting Sun Yat-sen University 2019-06-30
NCT03366415 Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC https://ClinicalTrials.gov/show/NCT03366415 Recruiting Fudan University 2023-12-31
NCT03707509 Phase III Study of Camrelizumab in Combination With Chemotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03707509 Active, not recruiting Jiangsu HengRui Medicine Co., Ltd. 2021-08-01
NCT03321539 Phase â…¢ Trial of Adjuvant Chemotherapy in Patients With N2-3 Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03321539 Recruiting Sun Yat-sen University 2020-12-31
NCT03283293 Target Volume Delineation After NACT in LA-NPCarcinoma Patients Treated With NACT+ CCRT https://ClinicalTrials.gov/show/NCT03283293 Completed Sun Yat-sen University 2007-04-30
NCT03282617 Dendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03282617 Recruiting National University Hospital, Singapore 2019-08-14
NCT03267498 Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC) https://ClinicalTrials.gov/show/NCT03267498 Recruiting University of California, San Francisco 2020-11-30
NCT03196869 the Study of Effect of Chronomodulated Chemotherapy on the Dendritic Cells Subsets in the Treatment of Advanced Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT03196869 Recruiting Guiyang Medical University 2019-04-12
NCT03177174 Different Chemotherapy Protocols Combined With Intensity Modulated Radiation Therapy in Patients With Locally Advanced Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03177174 Completed Chinese PLA General Hospital 2020-01-01
NCT03144661 An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies https://ClinicalTrials.gov/show/NCT03144661 Recruiting Incyte Corporation 2021-02-28
NCT03129412 Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic Lesions https://ClinicalTrials.gov/show/NCT03129412 Recruiting Zhejiang Cancer Hospital 2023-04-23
NCT03121716 A Study to Evaluate the Safety and Efficacy of SHR-1210, Gemcitabine and Cis-platinum by R/M NPC Subjects https://ClinicalTrials.gov/show/NCT03121716 Active, not recruiting Jiangsu HengRui Medicine Co., Ltd. 2019-04-30
NCT03097939 Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03097939 Recruiting National Cancer Centre, Singapore 2019-11-30
NCT03096808 Adaptive Radiotherapy for Head and Neck Cancer https://ClinicalTrials.gov/show/NCT03096808 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-03-15
NCT03074513 Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors https://ClinicalTrials.gov/show/NCT03074513 Recruiting M.D. Anderson Cancer Center 2021-03-31
NCT03047525 Study of DC-CTL Combined With CIK for Advanced Solid Tumor https://ClinicalTrials.gov/show/NCT03047525 Recruiting Harbin Medical University 2019-01-01
NCT03047265 Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03047265 Active, not recruiting Sun Yat-sen University 2025-12-01
NCT03044743 PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies https://ClinicalTrials.gov/show/NCT03044743 Recruiting The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 2020-03-31
NCT03020329 Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03020329 Recruiting Sun Yat-sen University 2020-12-30
NCT03007836 High-activity Natural Killer Immunotherapy for Small Metastases of Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT03007836 Completed Fuda Cancer Hospital, Guangzhou 2017-12-01
NCT02973386 Prognostic Analysis of Concurrent Chemoradiotherapy With/Without Adjuvant Chemotherapy for Locally Advanced NPC Patients https://ClinicalTrials.gov/show/NCT02973386 Recruiting Sun Yat-sen University 2020-12-31
NCT02958111 Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02958111 Active, not recruiting Sun Yat-sen University 2021-12-31
NCT02940925 TPC vs PF as Induction Chemotherapy Combined With CCRT for Stage IVa-b Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02940925 Active, not recruiting Sun Yat-sen University 2019-10-14
NCT02915445 EpCAM CAR-T for Treatment of Nasopharyngeal Carcinoma and Breast Cancer https://ClinicalTrials.gov/show/NCT02915445 Recruiting Sichuan University 2020-07-31
NCT02915432 The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC https://ClinicalTrials.gov/show/NCT02915432 Active, not recruiting Shanghai Junshi Bioscience Co., Ltd. 2019-09-30
NCT02874651 ADjuVant Apatinib in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy https://ClinicalTrials.gov/show/NCT02874651 Recruiting Sun Yat-sen University 2021-06-30
NCT02871518 Two Cycles Versus Three Cyclle of CCRT for Low Risk Locoregionally Advanced Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02871518 Recruiting Sun Yat-sen University 2018-07-31
NCT02794077 Cyclophosphamide for Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02794077 Completed The University of Hong Kong 2015-12-31
NCT02776124 Effect of Oral Supplements on the Nutritional Status of Locally Advanced Nasopharyngeal Carcinoma Patients https://ClinicalTrials.gov/show/NCT02776124 Completed Shanghai Ninth People’s Hospital Affiliated to Shanghai Jiao Tong University 2016-08-31
NCT02759250 A Study of ARGX-110 in Patients With Nasopharyngeal Carcinoma (NPC) https://ClinicalTrials.gov/show/NCT02759250 Completed argenx BVBA 2018-04-25
NCT02698111 Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02698111 Recruiting Suzhou Zelgen Biopharmaceuticals Co.,Ltd 2020-06-30
NCT02642107 Individualized Elective Neck Irradiation Based on MRI in NPC Patients https://ClinicalTrials.gov/show/NCT02642107 Active, not recruiting Sun Yat-sen University 2018-05-31
NCT02636231 Endostar for Locally Recurrent Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02636231 Recruiting Sun Yat-sen University 2019-12-31
NCT02633202 Concurrent Chemotherapy for the Intermediate Risk Nasopharyngeal Carcinoma In Intensity-modulated Radiotherapy Era https://ClinicalTrials.gov/show/NCT02633202 Recruiting Sun Yat-sen University 2019-12-31
NCT02633176 Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02633176 Recruiting Sun Yat-sen University 2023-01-31
NCT02627807 Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02627807 Active, not recruiting Sun Yat-sen University 2020-12-31
NCT02611960 Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122/KEYNOTE-122) https://ClinicalTrials.gov/show/NCT02611960 Active, not recruiting Merck Sharp & Dohme Corp. 2020-11-30
NCT02610556 Concurrent Docetaxel Plus Cisplatin or Cisplatin Alone With IMRT in High Risk Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02610556 Recruiting Sun Yat-sen University 2020-01-31
NCT02610010 Intensity-modulated Radiotherapy With or Without Concurrent Chemotherapy for Stage II Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02610010 Recruiting Sun Yat-sen University 2022-11-30
NCT02608073 A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT02608073 Completed Hoffmann-La Roche 2009-11-30
NCT02605967 Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02605967 Active, not recruiting Novartis 2020-08-27
NCT02590133 A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC https://ClinicalTrials.gov/show/NCT02590133 Recruiting Sun Yat-sen University 2018-12-31
NCT02584790 NBI to Detect Post-RT Mucosal Residual NPC https://ClinicalTrials.gov/show/NCT02584790 Completed Pamela Youde Nethersole Eastern Hospital 2017-04-30
NCT02582008 Bupropion Hydrochloride or Patient’s Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy https://ClinicalTrials.gov/show/NCT02582008 Active, not recruiting Wake Forest University Health Sciences 2019-09-28
NCT03403829 Maintenance Chemotherapy in High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 Stage https://ClinicalTrials.gov/show/NCT03403829 Recruiting Fudan University 2020-12-31
NCT02035527 Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck https://ClinicalTrials.gov/show/NCT02035527 Completed Ohio State University Comprehensive Cancer Center 2017-04-20
NCT03387774 Efficacy of Ulinastatin for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients https://ClinicalTrials.gov/show/NCT03387774 Recruiting Sun Yat-sen University 2020-12-31
NCT02538510 Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT02538510 Active, not recruiting University of Washington 2019-09-28
NCT02523430 HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA) for Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02523430 Completed Fuda Cancer Hospital, Guangzhou 2016-06-30
NCT02512315 A Trial On 4 Cycles Of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiation In N2-3 Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02512315 Recruiting Sun Yat-sen University 2024-12-31
NCT02507154 Reactivating NK Cells in Treating Refractory Head and Neck Cancer https://ClinicalTrials.gov/show/NCT02507154 Recruiting National University Hospital, Singapore 2019-08-31
NCT02500940 Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02500940 Recruiting Taichung Veterans General Hospital 2016-05-31
NCT02460887 The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT https://ClinicalTrials.gov/show/NCT02460887 Active, not recruiting Sun Yat-sen University 2021-06-30
NCT02460419 Maintenance Capecitabine Plus Best Supportive Care Versus Best Supportive Care for Metastatic Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02460419 Recruiting Sun Yat-sen University 2020-05-31
NCT02456506 Hyperfractionated Intensity-modulated Radiotherapy (IMRT) Versus Conventional Fraction IMRT for Patients With Loco-regionally Recurrent Nasopharyngeal Carcinoma. https://ClinicalTrials.gov/show/NCT02456506 Active, not recruiting Sun Yat-sen University 2022-12-31
NCT02434614 Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02434614 Active, not recruiting Guilin Medical University, China 2021-05-31
NCT02363400 A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA https://ClinicalTrials.gov/show/NCT02363400 Enrolling by invitation National Health Research Institutes, Taiwan 2019-12-31
NCT02360501 Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02360501 Completed Sun Yat-sen University 2016-03-31
NCT02339558 Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT02339558 Completed National Cancer Institute (NCI) 2018-06-16
NCT02309437 Early Use of Opioid in Radiation Mucositis https://ClinicalTrials.gov/show/NCT02309437 Completed Affiliated Cancer Hospital & Institute of Guangzhou Medical University 2017-12-31
NCT02287311 Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL) https://ClinicalTrials.gov/show/NCT02287311 Recruiting Baylor College of Medicine 2021-02-28
NCT02269943 Safety and Efficacy of CC-486 in Previously Treated Patients With Locally Advanced or Metastatic Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02269943 Completed Celgene 2017-04-20
NCT02143388 Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Randomized Control Clinical Trial https://ClinicalTrials.gov/show/NCT02143388 Active, not recruiting Sun Yat-sen University 2018-07-31
NCT02135042 Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA https://ClinicalTrials.gov/show/NCT02135042 Recruiting NRG Oncology 2021-07-31
NCT02123511 Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy https://ClinicalTrials.gov/show/NCT02123511 Completed Mayo Clinic 2016-03-22
NCT02113878 Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck https://ClinicalTrials.gov/show/NCT02113878 Active, not recruiting Dana-Farber Cancer Institute 2020-12-31
NCT02113423 Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02113423 Completed Fujian Cancer Hospital 2009-06-30
NCT02111460 Chemotherapy Combined With Radiotherapy vs Chemotherapy Alone for Distant Metastatic Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02111460 Active, not recruiting Sun Yat-sen University 2019-08-31
NCT02065362 TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC https://ClinicalTrials.gov/show/NCT02065362 Active, not recruiting Baylor College of Medicine 2017-03-31
NCT01316757 Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer https://ClinicalTrials.gov/show/NCT01316757 Completed Fox Chase Cancer Center 2015-04-07
NCT01309633 Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC) https://ClinicalTrials.gov/show/NCT01309633 Completed National University Hospital, Singapore 2019-03-11
NCT01271439 Study of Chemoradiotherapy Combined With Cetuximab in Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT01271439 Completed Sun Yat-sen University 2012-06-30
NCT03353467 Endoscopic Nasopharyngectomy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma Patients https://ClinicalTrials.gov/show/NCT03353467 Recruiting Sun Yat-sen University 2020-10-01
NCT02012062 Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPC https://ClinicalTrials.gov/show/NCT02012062 Completed Fudan University 2016-03-31
NCT01937793 Swallowing Exercises for Nasopharyngeal Cancer After Radiation Therapy https://ClinicalTrials.gov/show/NCT01937793 Completed National Taiwan University Hospital 2013-12-31
NCT01872962 Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT01872962 Active, not recruiting Sun Yat-sen University 2018-11-30
NCT01865201 Effect of Edaravone on Radiation-induced Temporal Lobe Necrosis https://ClinicalTrials.gov/show/NCT01865201 Completed Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 2011-10-31
NCT01847326 Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer https://ClinicalTrials.gov/show/NCT01847326 Recruiting University of Chicago 2021-04-30
NCT01817023 The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT https://ClinicalTrials.gov/show/NCT01817023 Recruiting Chinese Academy of Medical Sciences 2019-07-30
NCT01806675 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy https://ClinicalTrials.gov/show/NCT01806675 Completed Stanford University 2016-12-07
NCT01800071 A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT01800071 Completed Cancer Research UK 2017-03-10
NCT01797900 The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT https://ClinicalTrials.gov/show/NCT01797900 Completed Chinese Academy of Medical Sciences 2014-09-30
NCT01712919 Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC) https://ClinicalTrials.gov/show/NCT01712919 Completed Jiangsu Cancer Institute & Hospital 2014-03-31
NCT01637194 Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer https://ClinicalTrials.gov/show/NCT01637194 Completed Fox Chase Cancer Center 2011-07-31
NCT01621880 Effect of Bevacizumab on Radiation-induced Brain Necrosis in Patients With Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT01621880 Completed Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 2015-08-31
NCT01616849 Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT01616849 Completed Sun Yat-sen University 2015-07-31
NCT01596868 GP VS TP in the Treatment of Advanced Nasopharyngeal Carcinoma in Northwest China https://ClinicalTrials.gov/show/NCT01596868 Completed Fourth Military Medical University 2013-10-31
NCT01540136 Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT01540136 Completed Sun Yat-sen University 2014-05-31
NCT01534585 Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT01534585 Completed Taizhou Hospital 2013-02-28
NCT01469429 Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. https://ClinicalTrials.gov/show/NCT01469429 Completed Ohio State University Comprehensive Cancer Center 2014-09-17
NCT01462474 Concurrent Chemoradiotherapy With Famitinib for Patients With Locally Advanced Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT01462474 Completed Jiangsu HengRui Medicine Co., Ltd. 2015-08-31
NCT01449942 Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT01449942 Completed Xiangya Hospital of Central South University 2011-04-30
NCT01447056 Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases https://ClinicalTrials.gov/show/NCT01447056 Completed Baylor College of Medicine 2015-03-31
NCT01439724 Low-level Laser Therapy to Prevent Oral Mucositis in Head and Neck Patients https://ClinicalTrials.gov/show/NCT01439724 Completed Instituto Nacional de Cancer, Brazil 2008-06-30
NCT01392235 Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC) https://ClinicalTrials.gov/show/NCT01392235 Completed Jiangsu HengRui Medicine Co., Ltd. 2015-04-30
NCT01370070 MK-2206 in Recurrent Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT01370070 Completed Chinese University of Hong Kong 2016-12-31
NCT01365169 Post-op Wellness Program for Pancreatic Cancer Patients That Uses Patient Feedback and Real-time Provider Monitoring https://ClinicalTrials.gov/show/NCT01365169 Recruiting M.D. Anderson Cancer Center 2025-02-25
NCT01349933 Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer https://ClinicalTrials.gov/show/NCT01349933 Completed National Cancer Institute (NCI) 2013-10-31
NCT01344356 Stereotactic Body Radiotherapy for Head and Neck Tumors https://ClinicalTrials.gov/show/NCT01344356 Completed Mercy Research 2018-05-31
NCT01334177 TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck https://ClinicalTrials.gov/show/NCT01334177 Completed University of Washington 2014-06-30
NCT01326559 Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC) https://ClinicalTrials.gov/show/NCT01326559 Completed Hong Kong Nasopharyngeal Cancer Study Group Limited 2016-12-31
NCT04447612 Concurrent Chemoradiation and Durvalumab for Locoregionally Advanced Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT04447612 Recruiting The University of Hong Kong 2023-12-31
NCT04437329 Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT04437329 Recruiting Affiliated Cancer Hospital & Institute of Guangzhou Medical University 2028-06-30
NCT04436965 Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition https://ClinicalTrials.gov/show/NCT04436965 Recruiting Sun Yat-sen University 2024-06-15
NCT04405622 Toripalimab and Gemcitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma. https://ClinicalTrials.gov/show/NCT04405622 Recruiting Sun Yat-sen University 2021-05-31
NCT04398056 Chemotherapy Plus Subsequent Loco-regional Radiotherapy Combined With Toripalimab in the De Novo Metastatic Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT04398056 Recruiting Sun Yat-sen University 2021-04-01
NCT04396886 Bintrafusp Alfa in Previously Treated Patients With Recurrent and Metastatic (R/M) Non-keratinizing Nasopharyngeal Carcinoma (NPC) https://ClinicalTrials.gov/show/NCT04396886 Recruiting The University of Hong Kong 2024-02-23
NCT04350190 Apatinib Combined With PD-1 in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT04350190 Recruiting Guilin Medical University, China 2021-05-30
NCT04282070 SHR-1701 in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT04282070 Recruiting Jiangsu HengRui Medicine Co., Ltd. 2021-04-16
NCT04220528 Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC https://ClinicalTrials.gov/show/NCT04220528 Recruiting Fujian Cancer Hospital 2023-06-01
NCT04136886 Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT04136886 Recruiting Sun Yat-sen University 2027-12-31
NCT04073784 Gemcitabine Combined With Apatinib and Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma. https://ClinicalTrials.gov/show/NCT04073784 Recruiting Sun Yat-sen University 2021-01-01
NCT04072107 EPstein-barr Virus DNA Response to Systemic Therapy for Treatment Adaptation in High Risk NPC (EP-STAR) https://ClinicalTrials.gov/show/NCT04072107 Recruiting Sun Yat-sen University 2022-12-31
NCT04061278 A Multicenter, Prospective, Phase III Randomized Controlled Clinical Study for the Treatment of N2-3 Nasopharyngeal Carcinoma Patients https://ClinicalTrials.gov/show/NCT04061278 Recruiting Second Affiliated Hospital, School of Medicine, Zhejiang University 2022-06-30
NCT04015661 Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients With LA-NPC https://ClinicalTrials.gov/show/NCT04015661 Recruiting Fuzhou General Hospital 2020-12-01
NCT03930498 Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03930498 Recruiting Sun Yat-sen University 2021-11-30
NCT03925896 Phase I Trial of LMP2 Antigen-specific TCR T-cell Therapy for Recurrent and Metastatic NPC Patients https://ClinicalTrials.gov/show/NCT03925896 Recruiting Sun Yat-sen University 2020-08-01
NCT03925090 Phase II Trial of Neoadjuvant and Adjuvant Anti-PD-1 Antibody Toripalimab Combined With CCRT in NPC Patients https://ClinicalTrials.gov/show/NCT03925090 Recruiting Sun Yat-sen University 2021-10-31
NCT03924986 Tislelizumab Combined With Chemotherapy Versus Chemotherapy Alone in Recurrent or Metastatic Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT03924986 Recruiting BeiGene 2021-08-31
NCT03923842 Denosumab In Ebv Nasopharyngeal Carcinoma As A Model For RankMediated Immunologic Modulation Of Virus-Related Tumours https://ClinicalTrials.gov/show/NCT03923842 Recruiting Gruppo Oncologico del Nord-Ovest 2021-09-30
NCT03919552 Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03919552 Recruiting Nanfang Hospital of Southern Medical University 2023-01-31
NCT03915132 Nimotuzumab Combined With VMAT in Elderly Patients With Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03915132 Recruiting Chinese Academy of Medical Sciences 2020-05-01
NCT03908372 Optimized Treatment Strategies for Early and Medium Stage Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03908372 Recruiting Chinese Academy of Medical Sciences 2021-05-31
NCT03907826 Programmed Death-1 (PD-1) Antibody Combined With IMRT in Recurrent Nasopharyngeal Carcinoma Patients https://ClinicalTrials.gov/show/NCT03907826 Recruiting Sun Yat-sen University 2021-11-30
NCT03906058 Anlotinib in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients After Failure of no Less Than Second-line Therapy https://ClinicalTrials.gov/show/NCT03906058 Recruiting Sun Yat-sen University 2021-04-29
NCT03904225 Tegio Consolidation Therapy for NPC Patients With High Risk of Metastasis https://ClinicalTrials.gov/show/NCT03904225 Recruiting Zhejiang Cancer Hospital 2022-12-31
NCT03891953 Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors. https://ClinicalTrials.gov/show/NCT03891953 Recruiting Novartis 2022-11-28
NCT03890185 Docetaxal & Cisplatin vs LDFRT + Docetaxal & Cisplatin in Locally Advanced NPC https://ClinicalTrials.gov/show/NCT03890185 Active, not recruiting King Faisal Specialist Hospital & Research Center 2020-12-31
NCT03876574 Hepatic Artery Infusion Pump for NPC Liver Metastases https://ClinicalTrials.gov/show/NCT03876574 Completed Xiangya Hospital of Central South University 2017-12-31
NCT03854838 IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma. https://ClinicalTrials.gov/show/NCT03854838 Recruiting Sun Yat-sen University 2020-06-30
NCT03849469 A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT03849469 Recruiting Xencor, Inc. 2026-09-30
NCT03840421 GP vs PF as Induction Chemotherapy Combined With CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03840421 Recruiting Sun Yat-sen University 2023-02-14
NCT03839602 Delineation of Reducing Clinical Target Volume for Early-stage Nasopharyngeal Carcinoma Patients https://ClinicalTrials.gov/show/NCT03839602 Completed Sun Yat-sen University 2006-10-31
NCT03837808 Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03837808 Recruiting Sun Yat-sen University 2022-02-11
NCT03788499 Using Massage of Maxillofacial and Oral Cavity to Prevent Radioactive Oral Mucositis https://ClinicalTrials.gov/show/NCT03788499 Recruiting Xinqiao Hospital of Chongqing 2021-02-27
NCT03769467 Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC) https://ClinicalTrials.gov/show/NCT03769467 Recruiting Atara Biotherapeutics 2023-09-30
NCT03752398 A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) https://ClinicalTrials.gov/show/NCT03752398 Recruiting Xencor, Inc. 2024-09-30
NCT03734809 NEO-SPACE Trial: Pembrolizumab and Chemoradiation in Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT03734809 Recruiting Chinese University of Hong Kong 2022-12-31
NCT03720340 Acute Radiation Oral Mucositis in Nasopharyngeal Carcinoma(NPC) Patients Treated With Combined Radio-Chemotherapy https://ClinicalTrials.gov/show/NCT03720340 Recruiting Zhejiang Cancer Hospital 2021-08-31
NCT03708822 Study of Docetaxel and Cisplatin Combined With Nimotuzumab As First-Line Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03708822 Recruiting Sun Yat-sen University 2020-12-30
NCT03701451 Demethylated Drug in the Treatment of Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03701451 Recruiting Guilin Medical University, China 2020-12-01
NCT03700476 Sintilimab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03700476 Recruiting Sun Yat-sen University 2023-01-31
NCT03668730 Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03668730 Recruiting Sun Yat-sen University 2023-12-30
NCT03668366 S-1 Combined With IMRT Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03668366 Active, not recruiting Fudan University 2018-12-01
NCT03666221 Nimotuzumab for Recurrent Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03666221 Recruiting Fujian Cancer Hospital 2020-04-01
NCT03657017 PET/MR in Locally Advanced Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03657017 Recruiting Zhejiang Cancer Hospital 2022-06-01
NCT03656965 EBV Positive Nasopharyngeal Carcinoma Treated With Concurrent Chemo-radiotherapy With or Without Anti-Viral Drug https://ClinicalTrials.gov/show/NCT03656965 Active, not recruiting Kuwait Cancer Control Center 2021-05-31
NCT03639467 Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03639467 Recruiting Chinese Academy of Medical Sciences 2021-08-22
NCT03604965 GP Induction Chemotherapy us TPF Adjuvant Chemotherapy Combined With DDP Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC https://ClinicalTrials.gov/show/NCT03604965 Recruiting Guiyang Medical University 2020-07-21
NCT03601975 Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03601975 Recruiting Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 2020-07-30
NCT03598218 Hypofractionated Versus Conventionally Fractionated Radiotherapy for Initial Distant Metastases Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03598218 Recruiting Guilin Medical University, China 2020-07-13
NCT03578575 To Investigate the Molecular Mechanism of Traditional Chinese Medicine Constitution Using Next-generation Sequencing in Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03578575 Recruiting China Medical University Hospital 2020-07-31
NCT03574324 TPF Induction Chemotherapy vs PF Adjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC https://ClinicalTrials.gov/show/NCT03574324 Recruiting Guiyang Medical University 2023-05-24
NCT03558191 SHR-1210 in Recurrent/Metastatic Nasopharyngeal Carcinoma Who Have Received Previous At Least Two Lines of Chemotherapy. https://ClinicalTrials.gov/show/NCT03558191 Active, not recruiting Jiangsu HengRui Medicine Co., Ltd. 2020-06-30
NCT03557112 By Comparing TPF Induction Chemotherapy Combined With Nimotuzumab Concurrent Radiotherapy and Cisplatin Concurrent Radio-chemotherapy for Locally Advanced NPC https://ClinicalTrials.gov/show/NCT03557112 Recruiting Guiyang Medical University 2021-06-01
NCT03517488 A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT03517488 Recruiting Xencor, Inc. 2020-12-31
NCT03427827 Camrelizumab (PD-1 Antibody) After Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma (PACIFIC-NPC) https://ClinicalTrials.gov/show/NCT03427827 Recruiting Sun Yat-sen University 2022-02-28
NCT03427359 Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03427359 Completed The University of Hong Kong-Shenzhen Hospital 2017-12-31
NCT01249547 Nasopharyngeal Carcinoma (NPC) Axitinib https://ClinicalTrials.gov/show/NCT01249547 Completed Chinese University of Hong Kong 2016-12-31
NCT01187238 The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT01187238 Completed Chinese Academy of Medical Sciences 2013-05-31
NCT01155609 L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer https://ClinicalTrials.gov/show/NCT01155609 Completed University of Washington 2011-12-31
NCT01094405 Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy https://ClinicalTrials.gov/show/NCT01094405 Active, not recruiting Chinese University of Hong Kong 2021-12-31
NCT00982449 124I-FIAU Imaging in EBV and KSHV Associated Cancers https://ClinicalTrials.gov/show/NCT00982449 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2013-07-31
NCT00953420 Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes https://ClinicalTrials.gov/show/NCT00953420 Completed Baylor College of Medicine 2014-06-30
NCT00939627 Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab https://ClinicalTrials.gov/show/NCT00939627 Completed National Cancer Institute (NCI) 2013-01-31
NCT00896181 Phase 2 Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC) https://ClinicalTrials.gov/show/NCT00896181 Active, not recruiting Stanford University 2019-11-11
NCT04425265 Plasma Radiofrequency Ablation at Low Temperature Versus Electrocautery Block Resection at High Frequency for Localized Recurrent Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT04425265 Recruiting Sun Yat-sen University 2024-06-30
NCT04223024 Concurrent Chemoradiotherapy With Nimotuzumab for High Risk Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT04223024 Recruiting Sun Yat-sen University 2022-12-31
NCT03866967 A Study of Anti-PD-1 AK105 in Patients With Metastatic Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03866967 Recruiting Akeso 2020-06-15
NCT03429868 PET and MRI in Prognosis Prediction of NPC https://ClinicalTrials.gov/show/NCT03429868 Recruiting Chang Gung Memorial Hospital 2020-07-31
NCT03213587 Apatinib in Treating Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) https://ClinicalTrials.gov/show/NCT03213587 Recruiting Zhejiang Cancer Hospital 2020-07-31
NCT02795195 Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Locally Recurrent Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02795195 Active, not recruiting Shanghai Proton and Heavy Ion Center 2020-12-31
NCT00834093 A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT00834093 Active, not recruiting Dana-Farber Cancer Institute 2020-12-31
NCT04448522 Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT04448522 Recruiting Sun Yat-sen University 2026-06-30
NCT02948699 A Research About Nutrition Impact for Local Advanced Nasopharyngeal Carcinoma Patients https://ClinicalTrials.gov/show/NCT02948699 Active, not recruiting Zhejiang Cancer Hospital 2018-11-30
NCT00815087 Functional Electrical Stimulation in Irradiated Nasopharyngeal Carcinoma (NPC) https://ClinicalTrials.gov/show/NCT00815087 Completed National Taiwan University Hospital 2009-02-28
NCT04417985 Prognostic Utility of the Imaging and Biological Signatures in Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT04417985 Completed Chang Gung Memorial Hospital 2014-07-31
NCT03791944 3DV+TPS Applied to Radiotherapy for Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03791944 Recruiting Xinqiao Hospital of Chongqing 2019-01-31
NCT03612219 Adjuvant Treatment of Apatinib in Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03612219 Recruiting Guilin Medical University, China 2021-07-28
NCT03306121 TPF+CCRT vs.CCRT+PF in High Risk Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03306121 Recruiting Sun Yat-sen University 2020-11-09
NCT03082534 Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma https://ClinicalTrials.gov/show/NCT03082534 Recruiting University of California, San Diego 2019-12-30
NCT03015727 Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03015727 Recruiting Zhejiang Cancer Hospital 2022-12-31
NCT02578641 A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) Patients https://ClinicalTrials.gov/show/NCT02578641 Active, not recruiting Tessa Therapeutics 2021-02-28
NCT02834013 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors https://ClinicalTrials.gov/show/NCT02834013 Recruiting National Cancer Institute (NCI) 2021-08-31
NCT04384627 Reducing Target Volumes in NPC Treated With Induction Chemotherapy Followed by Concurrent Chemoradiotherapy https://ClinicalTrials.gov/show/NCT04384627 Active, not recruiting Sun Yat-sen University 2020-10-01
NCT00778908 Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT00778908 Completed Guangxi Medical University 2011-01-31
NCT00747799 Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) https://ClinicalTrials.gov/show/NCT00747799 Completed Sun Yat-sen University 2011-05-31
NCT00717184 A Pilot Study of Autologous Ex Vivo Activated NK Cell Infusion in the Treatment of Metastatic Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT00717184 Completed National University Hospital, Singapore NA
NCT00706316 Administration of Epstein Barr Virus - Specific Cytotoxic T-Lymphocytes to Metastatic EBV-Positive Nasopharygneal Cancer https://ClinicalTrials.gov/show/NCT00706316 Completed University Health Network, Toronto 2009-08-31
NCT00700440 Study of Cetuximab in Nasopharyngeal Carcinoma (NPC) With Chemoradiotherapy https://ClinicalTrials.gov/show/NCT00700440 Completed Sun Yat-sen University 2009-04-30
NCT00697905 Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT00697905 Completed Ministry of Health, Malaysia 2011-05-31
NCT00697619 To Evaluate the Efficacy of ZOMETA® in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT00697619 Completed Sun Yat-sen University 2009-01-31
NCT00630149 Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy https://ClinicalTrials.gov/show/NCT00630149 Completed Sun Yat-sen University 2011-11-30
NCT00609219 T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC https://ClinicalTrials.gov/show/NCT00609219 Completed Baylor College of Medicine 2007-10-31
NCT00603915 A Study of Gemcitabine and Cisplatin/Carboplatin Plus Erlotinib in Patients With Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT00603915 Completed University Health Network, Toronto 2010-12-31
NCT00592501 Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT00592501 Completed Massachusetts General Hospital 2019-04-30
NCT00565448 Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents https://ClinicalTrials.gov/show/NCT00565448 Completed Sanofi 2009-03-31
NCT00535795 Phase III: Assess Conventional RT w/ Conventional Plus Accelerated Boost RT in the Treatment of Nasopharyngeal CA https://ClinicalTrials.gov/show/NCT00535795 Completed King Faisal Specialist Hospital & Research Center 2015-09-30
NCT00516087 LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA) https://ClinicalTrials.gov/show/NCT00516087 Completed Baylor College of Medicine 2012-12-31
NCT00513435 Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer https://ClinicalTrials.gov/show/NCT00513435 Completed National Cancer Institute (NCI) 2011-03-31
NCT00507767 Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer https://ClinicalTrials.gov/show/NCT00507767 Completed National Cancer Institute (NCI) 2010-02-28
NCT00492089 Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer https://ClinicalTrials.gov/show/NCT00492089 Completed National Cancer Institute (NCI) 2010-08-31
NCT00470496 Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer https://ClinicalTrials.gov/show/NCT00470496 Completed Roswell Park Cancer Institute 2011-10-28
NCT00454142 Pazopanib Hydrochloride in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT00454142 Completed National Cancer Institute (NCI) 2010-04-30
NCT00439426 A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer. https://ClinicalTrials.gov/show/NCT00439426 Completed Hoffmann-La Roche 2009-09-30
NCT00436800 Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT00436800 Completed Sanofi 2008-10-31
NCT00436293 Taxotere + Cisplatin in Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT00436293 Completed Sanofi 2010-03-31
NCT00431210 Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT00431210 Completed Dana-Farber Cancer Institute 2015-06-30
NCT00430378 Acupuncture for Prevention of Radiation-Induced Xerostomia https://ClinicalTrials.gov/show/NCT00430378 Active, not recruiting M.D. Anderson Cancer Center 2021-01-31
NCT00410826 Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer https://ClinicalTrials.gov/show/NCT00410826 Completed University of Washington 2012-05-31
NCT00408694 Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT00408694 Completed National Cancer Institute (NCI) 2011-12-15
NCT00397384 Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer https://ClinicalTrials.gov/show/NCT00397384 Completed National Cancer Institute (NCI) 2013-06-30
NCT00387335 Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer https://ClinicalTrials.gov/show/NCT00387335 Completed National Cancer Institute (NCI) 2010-03-31
NCT00379262 Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT00379262 Completed Hong Kong Nasopharyngeal Cancer Study Group Limited 2017-05-31
NCT00370890 A Trial of Adjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy https://ClinicalTrials.gov/show/NCT00370890 Active, not recruiting Chinese University of Hong Kong 2020-12-31
NCT00305734 Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT00305734 Completed National Cancer Institute (NCI) 2007-07-31
NCT00274937 Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT00274937 Active, not recruiting Children’s Oncology Group 2016-03-31
NCT00212108 A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839 https://ClinicalTrials.gov/show/NCT00212108 Completed National University Hospital, Singapore 2007-03-31
NCT00201396 A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT00201396 Completed National Health Research Institutes, Taiwan 2009-08-31
NCT00141765 Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers https://ClinicalTrials.gov/show/NCT00141765 Completed University of Michigan Rogel Cancer Center 2008-12-31
NCT00123864 Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function https://ClinicalTrials.gov/show/NCT00123864 Completed AHS Cancer Control Alberta NA
NCT00114283 Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer https://ClinicalTrials.gov/show/NCT00114283 Completed National Cancer Institute (NCI) 2006-10-31
NCT00103259 Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck https://ClinicalTrials.gov/show/NCT00103259 Completed National Cancer Institute (NCI) 2011-11-30
NCT00101348 Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00101348 Completed National Cancer Institute (NCI) 2007-10-31
NCT00101270 Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas https://ClinicalTrials.gov/show/NCT00101270 Completed National Cancer Institute (NCI) 2007-09-30
NCT00098631 Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer https://ClinicalTrials.gov/show/NCT00098631 Completed National Cancer Institute (NCI) 2006-12-31
NCT00096512 S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer https://ClinicalTrials.gov/show/NCT00096512 Completed National Cancer Institute (NCI) 2006-05-31
NCT00091182 Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment https://ClinicalTrials.gov/show/NCT00091182 Completed National Cancer Institute (NCI) 2006-02-28
NCT00089362 Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors https://ClinicalTrials.gov/show/NCT00089362 Completed National Cancer Institute (NCI) 2008-01-31
NCT00078546 EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC) https://ClinicalTrials.gov/show/NCT00078546 Completed Baylor College of Medicine 2007-01-31
NCT00078494 Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT00078494 Completed National Institutes of Health Clinical Center (CC) NA
NCT00004074 Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu https://ClinicalTrials.gov/show/NCT00004074 Completed National Cancer Institute (NCI) 2009-02-28
NCT00068497 Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00068497 Completed National Cancer Institute (NCI) 2007-12-31
NCT00063895 Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck https://ClinicalTrials.gov/show/NCT00063895 Completed National Cancer Institute (NCI) 2005-10-31
NCT00057785 Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT00057785 Completed Radiation Therapy Oncology Group 2007-02-28
NCT00055913 Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer https://ClinicalTrials.gov/show/NCT00055913 Completed National Cancer Institute (NCI) 2007-09-30
NCT00049283 Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer https://ClinicalTrials.gov/show/NCT00049283 Completed National Cancer Institute (NCI) 2008-02-29
NCT00031681 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) https://ClinicalTrials.gov/show/NCT00031681 Completed National Cancer Institute (NCI) 2011-01-31
NCT00023959 Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer https://ClinicalTrials.gov/show/NCT00023959 Completed National Cancer Institute (NCI) 2010-03-31
NCT00055770 Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer https://ClinicalTrials.gov/show/NCT00055770 Completed National Cancer Institute (NCI) 2006-12-31
NCT00030498 Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction https://ClinicalTrials.gov/show/NCT00030498 Completed National Cancer Institute (NCI) 2007-07-31

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03314051 Long-term Treatment Outcome for Stage III NPC Patients and Risk Grouping by Plasma EBV DNA https://ClinicalTrials.gov/show/NCT03314051 Completed Taichung Veterans General Hospital 2013-05-01
NCT03290001 The Influence of Anxiety and Depression on Survival in Nasopharyngeal Carcinoma Patients https://ClinicalTrials.gov/show/NCT03290001 Recruiting Sun Yat-sen University 2022-09-20
NCT03240835 The Function of PA, RBP and TRSF in Malnutrition Detecting and Nutritional Status Monitoring for NPC Patients https://ClinicalTrials.gov/show/NCT03240835 Active, not recruiting Sun Yat-sen University 2018-12-31
NCT03010150 Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer https://ClinicalTrials.gov/show/NCT03010150 Recruiting M.D. Anderson Cancer Center 2019-12-31
NCT03003182 A Study of Nasopharyngeal Carcinoma From Guangdong https://ClinicalTrials.gov/show/NCT03003182 Recruiting Sun Yat-sen University 2019-05-31
NCT02604472 Retrospective Investigation of the Impacts of Prognosis for Nasopharyngeal Carcinoma Patients https://ClinicalTrials.gov/show/NCT02604472 Completed Sun Yat-sen University 2013-06-30
NCT02597426 Nasopharyngeal Carcinoma Post IMRT https://ClinicalTrials.gov/show/NCT02597426 Active, not recruiting University Health Network, Toronto 2020-09-30
NCT02586532 Evaluation of the Sensitivity of Endoscopy to Detect Nasopharyngeal Carcinoma (NPC) in an Epstein-Barr Virus (EBV)-Based NPC Screening Project in China https://ClinicalTrials.gov/show/NCT02586532 Recruiting National Institutes of Health Clinical Center (CC) 2021-12-31
NCT02575547 Effect of Chemoradiotherapy on Nutritional Status in Advanced NPC Patients https://ClinicalTrials.gov/show/NCT02575547 Active, not recruiting Sun Yat-sen University 2016-09-30
NCT03398980 Late Sequelae of Childhood and Adolescent Nasopharyngeal Carcinoma Survivors After Radiotherapy https://ClinicalTrials.gov/show/NCT03398980 Completed Sun Yat-sen University 2017-01-10
NCT02505139 The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC Patients https://ClinicalTrials.gov/show/NCT02505139 Completed Sun Yat-sen University 2016-07-31
NCT02501993 Nasopharyngeal Carcinoma Screening in Zhongshan City https://ClinicalTrials.gov/show/NCT02501993 Recruiting Zhongshan People’s Hospital, Guangdong, China 2022-03-31
NCT02245100 Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT02245100 Recruiting Thomas Jefferson University 2020-07-31
NCT02211677 Hemoglobin, Neutrophil to Lymphocyte Ratio and Platelet Count Improve Prognosis Prediction in Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02211677 Recruiting Sun Yat-sen University 2019-12-31
NCT02199132 Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc Tauli https://ClinicalTrials.gov/show/NCT02199132 Completed Corporacion Parc Tauli 2014-10-31
NCT02149641 Parotid-sparing IMRT for Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT02149641 Completed Royal Marsden NHS Foundation Trust 2011-04-30
NCT02063399 Prospective Nasopharyngeal Carcinoma Screening Using Plasma Epstein-Barr Virus DNA Analysis https://ClinicalTrials.gov/show/NCT02063399 Active, not recruiting Chinese University of Hong Kong 2016-08-31
NCT01379872 Assessment of New Radiation Oncology Technologies and Treatments https://ClinicalTrials.gov/show/NCT01379872 Completed Trans-Tasman Radiation Oncology Group (TROG) 2012-05-31
NCT01365208 New Approach of Assessing Drug Response for Treatment of Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT01365208 Completed Chinese University of Hong Kong 2017-03-03
NCT04094545 Intestinal Flora Sequencing for Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT04094545 Completed The Third Xiangya Hospital of Central South University 2018-12-31
NCT03989297 PD-L1 and BRAF Expression in Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03989297 Recruiting Kiang Wu Hospital 2019-12-01
NCT03981224 The Value of Post-radiation Detectable Plasma EBV DNA in High-risk Nasopharyngeal Carcinoma Patients https://ClinicalTrials.gov/show/NCT03981224 Completed Taichung Veterans General Hospital 2013-05-01
NCT03855020 Serial Epstein-Barr Virus DNA Surveillance in Nasopharyngeal Carcinoma Patients https://ClinicalTrials.gov/show/NCT03855020 Recruiting Sun Yat-sen University 2022-05-10
NCT03830996 Weekly Plasma EBV DNA for Non-metastatic Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03830996 Recruiting The University of Hong Kong 2020-12-31
NCT03810274 3DV+TPS Software Outlines the Radiotherapy of Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT03810274 Completed Xinqiao Hospital of Chongqing 2018-12-31
NCT03656250 Assessment of Treatment Response of Nasopharyngeal Cancer Using Simultaneous 18F-FDG-PET and MRI https://ClinicalTrials.gov/show/NCT03656250 Completed NYU Langone Health 2018-11-19
NCT03647527 Predictor Analysis of Acute Radiation Oral Mucositis in NPC Patients Treated With IMRT/TOMO Combined Chemotherapy https://ClinicalTrials.gov/show/NCT03647527 Recruiting Zhejiang Cancer Hospital 2018-11-30
NCT03601390 Combining PET/CT and EBV DNA to Evaluate the Hazard of Progression in the Follow-up of Locally Advanced NPC https://ClinicalTrials.gov/show/NCT03601390 Recruiting Sun Yat-sen University 2019-12-01
NCT03588403 TOMO Versus IMRT in Nasopharyngeal Carcinoma Patients https://ClinicalTrials.gov/show/NCT03588403 Recruiting Zhejiang Cancer Hospital 2022-07-31
NCT03448341 Clinical and Instrumental Evaluation of Late Dysphagia in Patients With Oropharynx and Nasopharynx Cancer, Candidates to Combined Radiochemotherapy With Intensity Modulated Technique (IMRT) https://ClinicalTrials.gov/show/NCT03448341 Recruiting Azienda Ospedaliero, Universitaria Pisana 2022-07-16
NCT03411954 Hippocampus Avoidance During Intensity Modulated Radiotherapy for T4 Nasopharyngeal Carcinoma Patients https://ClinicalTrials.gov/show/NCT03411954 Recruiting Zhejiang Cancer Hospital 2021-02-28
NCT03670342 Pilot Study of Somatostatin Receptor Imaging in Nasopharyngeal Cancer https://ClinicalTrials.gov/show/NCT03670342 Completed National Cancer Centre, Singapore 2019-04-15
NCT02476669 Serial Plasma EBV DNA for Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02476669 Recruiting The University of Hong Kong 2020-12-31
NCT03973723 Plasma EBV DNA Monitoring in Post-treatment NPC Patients https://ClinicalTrials.gov/show/NCT03973723 Completed Taichung Veterans General Hospital 2013-12-31
NCT00341146 Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s) https://ClinicalTrials.gov/show/NCT00341146 Completed National Institutes of Health Clinical Center (CC) 2006-08-20
NCT00188253 Positron Emission Tomography Scanning and Epstein-Barr Virus DNA Levels in the Staging and Follow-up of Nasopharyngeal Carcinoma. https://ClinicalTrials.gov/show/NCT00188253 Active, not recruiting University Health Network, Toronto 2017-02-28
NCT00186433 A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations https://ClinicalTrials.gov/show/NCT00186433 Completed Stanford University 2013-06-30
NCT00173836 Swallowing Pattern of Patients With Nasopharyngeal Cancer Before and After Radiation Therapy: Longitudinal Study and Correction With Saliva Amount https://ClinicalTrials.gov/show/NCT00173836 Completed National Taiwan University Hospital 2006-08-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02689609 Post-radiation Hypothyroidism After IMRT for Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT02689609 Completed The University of Hong Kong 2013-12-31
NCT02012699 Integrated Cancer Repository for Cancer Research https://ClinicalTrials.gov/show/NCT02012699 Recruiting University of Nebraska 2099-12-31
NCT04108338 Prospective Comparisons of Clinical Trial and Real-world Outcomes in Nasopharyngeal Carcinoma https://ClinicalTrials.gov/show/NCT04108338 Completed Sun Yat-sen University 2019-07-01
NCT04085900 Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City https://ClinicalTrials.gov/show/NCT04085900 Recruiting Zhongshan People’s Hospital, Guangdong, China 2029-09-30